Copyright Reports & Markets. All rights reserved.

Global Occupational Medicines Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Occupational Medicines Industry
  • 1.7 COVID-19 Impact: Occupational Medicines Market Trends

    • 2 Global Occupational Medicines Quarterly Market Size Analysis

    • 2.1 Occupational Medicines Business Impact Assessment - COVID-19
      • 2.1.1 Global Occupational Medicines Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Occupational Medicines Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Occupational Medicines Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Occupational Medicines Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Occupational Medicines Market
    • 3.4 Key Players Occupational Medicines Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Occupational Medicines Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Chemical Poisoning
      • 1.4.2 Psychological Disorder
      • 1.4.3 Non-Induced Hearing Loss and Vibration
      • 1.4.4 Skin Disorder
      • 1.4.5 Chronic Respiratory Disease
      • 1.4.6 Pneumoconiosis
      • 1.4.7 Musculoskeletal Disorder
      • 1.4.8 Cancer
      • 1.4.9 Others
    • 4.2 By Type, Global Occupational Medicines Market Size, 2019-2021

    5 Impact of Covid-19 on Occupational Medicines Segments, By Application

    • 5.1 Overview
      • 5.5.1 Agriculture and Forestry
      • 5.5.2 Construction
      • 5.5.3 Manufacturing
      • 5.5.4 Petroleum and Mining
      • 5.5.5 Transportation
      • 5.5.6 Others
    • 5.2 By Application, Global Occupational Medicines Market Size, 2019-2021
      • 5.2.1 By Application, Global Occupational Medicines Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Amgen
      • 7.1.1 Amgen Business Overview
      • 7.1.2 Amgen Occupational Medicines Quarterly Revenue, 2020
      • 7.1.3 Amgen Occupational Medicines Product Introduction
      • 7.1.4 Amgen Response to COVID-19 and Related Developments
    • 7.2 AstraZeneca PLC
      • 7.2.1 AstraZeneca PLC Business Overview
      • 7.2.2 AstraZeneca PLC Occupational Medicines Quarterly Revenue, 2020
      • 7.2.3 AstraZeneca PLC Occupational Medicines Product Introduction
      • 7.2.4 AstraZeneca PLC Response to COVID-19 and Related Developments
    • 7.3 Bristol-Myers Squibb Company
      • 7.3.1 Bristol-Myers Squibb Company Business Overview
      • 7.3.2 Bristol-Myers Squibb Company Occupational Medicines Quarterly Revenue, 2020
      • 7.3.3 Bristol-Myers Squibb Company Occupational Medicines Product Introduction
      • 7.3.4 Bristol-Myers Squibb Company Response to COVID-19 and Related Developments
    • 7.4 Eli Lilly and Company
      • 7.4.1 Eli Lilly and Company Business Overview
      • 7.4.2 Eli Lilly and Company Occupational Medicines Quarterly Revenue, 2020
      • 7.4.3 Eli Lilly and Company Occupational Medicines Product Introduction
      • 7.4.4 Eli Lilly and Company Response to COVID-19 and Related Developments
    • 7.5 F. Hoffmann-La Roche Ltd
      • 7.5.1 F. Hoffmann-La Roche Ltd Business Overview
      • 7.5.2 F. Hoffmann-La Roche Ltd Occupational Medicines Quarterly Revenue, 2020
      • 7.5.3 F. Hoffmann-La Roche Ltd Occupational Medicines Product Introduction
      • 7.5.4 F. Hoffmann-La Roche Ltd Response to COVID-19 and Related Developments
    • 7.6 Johnson and Johnson
      • 7.6.1 Johnson and Johnson Business Overview
      • 7.6.2 Johnson and Johnson Occupational Medicines Quarterly Revenue, 2020
      • 7.6.3 Johnson and Johnson Occupational Medicines Product Introduction
      • 7.6.4 Johnson and Johnson Response to COVID-19 and Related Developments
    • 7.7 Nestl S.A. (Galderma S.A.)
      • 7.7.1 Nestl S.A. (Galderma S.A.) Business Overview
      • 7.7.2 Nestl S.A. (Galderma S.A.) Occupational Medicines Quarterly Revenue, 2020
      • 7.7.3 Nestl S.A. (Galderma S.A.) Occupational Medicines Product Introduction
      • 7.7.4 Nestl S.A. (Galderma S.A.) Response to COVID-19 and Related Developments
    • 7.8 Novartis AG
      • 7.8.1 Novartis AG Business Overview
      • 7.8.2 Novartis AG Occupational Medicines Quarterly Revenue, 2020
      • 7.8.3 Novartis AG Occupational Medicines Product Introduction
      • 7.8.4 Novartis AG Response to COVID-19 and Related Developments
    • 7.9 Pfizer
      • 7.9.1 Pfizer Business Overview
      • 7.9.2 Pfizer Occupational Medicines Quarterly Revenue, 2020
      • 7.9.3 Pfizer Occupational Medicines Product Introduction
      • 7.9.4 Pfizer Response to COVID-19 and Related Developments
    • 7.10 Sanofi
      • 7.10.1 Sanofi Business Overview
      • 7.10.2 Sanofi Occupational Medicines Quarterly Revenue, 2020
      • 7.10.3 Sanofi Occupational Medicines Product Introduction
      • 7.10.4 Sanofi Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Occupational Medicines, including the following market information:
      Global Occupational Medicines Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Occupational Medicines Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Occupational Medicines Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Occupational Medicines Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Amgen, AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson and Johnson, Nestl S.A. (Galderma S.A.), Novartis AG, Pfizer, Sanofi, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Chemical Poisoning
      Psychological Disorder
      Non-Induced Hearing Loss and Vibration
      Skin Disorder
      Chronic Respiratory Disease
      Pneumoconiosis
      Musculoskeletal Disorder
      Cancer
      Others

      Based on the Application:
      Agriculture and Forestry
      Construction
      Manufacturing
      Petroleum and Mining
      Transportation
      Others

      Buy now